Treatment with dupilumab is safe and effective for patients with bullous pemphigoid, with complete remission seen as early as 4 weeks of treatment.

Several adverse health outcomes are associated with AD, such as atopic and allergic conditions, immune mediated conditions, and more.

The FDA has approved Bimzelx® (bimekizumab-bkzx) for the treatment of moderate to severe hidradenitis suppurativa in adults.

Adhering to a healthy prenatal diet may reduce patterns of infant growth outside reference ranges, according to study findings.

From 2021 to 2022, there was a decrease in the number of abortions performed, as well as in the abortion rate and ratio.

Work-time, rather than leisure-time or nonworkday, activity behavior seems to be associated with 24-hour ambulatory blood pressure.